| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Spero Therapeutics, Inc. | CEO & President | Common Stock | 1.14M | $1.54M | $1.35 | Aug 27, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | Aug 27, 2024 | 1 | -$3.72K | 4 | Aug 29, 2024 | CEO & President |
| SPRO | Spero Therapeutics, Inc. | Aug 2, 2024 | 2 | -$42.6K | 4 | Aug 6, 2024 | CEO and President |
| SPRO | Spero Therapeutics, Inc. | Feb 1, 2024 | 3 | -$108K | 4 | Feb 5, 2024 | CEO and President, Director |
| SPRO | Spero Therapeutics, Inc. | Aug 28, 2023 | 2 | -$7.75K | 4 | Aug 30, 2023 | CEO and President, Director |
| SPRO | Spero Therapeutics, Inc. | Aug 1, 2023 | 1 | $0 | 4 | Aug 3, 2023 | CEO and President, Director |
| SPRO | Spero Therapeutics, Inc. | Feb 1, 2023 | 2 | -$17.4K | 4 | Feb 3, 2023 | Chief Financial Officer |
| SPRO | Spero Therapeutics, Inc. | Aug 29, 2022 | 1 | -$5.38K | 4 | Aug 30, 2022 | Chief Financial Officer |
| SPRO | Spero Therapeutics, Inc. | Feb 1, 2022 | 2 | $0 | 4 | Feb 3, 2022 | Chief Financial Officer |
| SPRO | Spero Therapeutics, Inc. | Aug 26, 2021 | 1 | $0 | 4 | Aug 30, 2021 | Chief Financial Officer |